Paperpal Prime Logo

BMC pharmacology & toxicology : Impact Factor & More

eISSN: 2050-6511pISSN: 2050-6511
JournalOpen Access

Key Metrics

CiteScore
4.2
Impact Factor
< 5
SJR
Q3Pharmacology
SNIP
0.95
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on BMC pharmacology & toxicology

BMC pharmacology & toxicology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2190 | USD 2690 | GBP 1890
Publication Time12
Editorial Review ProcessOpen peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessOpen peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in BMC pharmacology & toxicology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in BMC pharmacology & toxicology

Antioxidant response and neurotransmitter modulation driven by oleuropein/alpha-lipoic acid attenuates lead-induced reproductive toxicity and neurotoxicity in Drosophila melanogaster
  • 6 Aug 2026
  • BMC Pharmacology and Toxicology
Drug-drug interaction between ticagrelor and fazamorexant: pharmacokinetic alterations in healthy subjects from a phase I, open-label, fixed-sequence study.
  • 22 Jul 2026
  • BMC pharmacology & toxicology
Elucidating metabolic dysfunction induced by titanium dioxide in intestinal epithelial cells using an integrative approach of metabolomics and transcriptomics.
  • 21 Jul 2026
  • BMC pharmacology & toxicology
Cardiac effects of prolonged recombinant human interleukin-11 treatment in severe thrombocytopenia: a retrospective cohort study.
  • 20 Jul 2026
  • BMC pharmacology & toxicology
In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models.
  • 15 Jul 2026
  • BMC pharmacology & toxicology
Pycnogenol attenuates thioacetamide-induced neurobehavioral impairment and hepatotoxicity via multi-target molecular modulation.
  • 11 Jul 2026
  • BMC pharmacology & toxicology
Antioxidant response and neurotransmitter modulation driven by oleuropein/alpha-lipoic acid attenuates lead-induced reproductive toxicity and neurotoxicity in Drosophila melanogaster
  • 6 Aug 2026
  • BMC Pharmacology and Toxicology
Drug-drug interaction between ticagrelor and fazamorexant: pharmacokinetic alterations in healthy subjects from a phase I, open-label, fixed-sequence study.
  • 22 Jul 2026
  • BMC pharmacology & toxicology
Elucidating metabolic dysfunction induced by titanium dioxide in intestinal epithelial cells using an integrative approach of metabolomics and transcriptomics.
  • 21 Jul 2026
  • BMC pharmacology & toxicology
Cardiac effects of prolonged recombinant human interleukin-11 treatment in severe thrombocytopenia: a retrospective cohort study.
  • 20 Jul 2026
  • BMC pharmacology & toxicology
In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models.
  • 15 Jul 2026
  • BMC pharmacology & toxicology
Pycnogenol attenuates thioacetamide-induced neurobehavioral impairment and hepatotoxicity via multi-target molecular modulation.
  • 11 Jul 2026
  • BMC pharmacology & toxicology

FAQs on BMC pharmacology & toxicology